These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3195147)

  • 1. [The indirect hemagglutination reaction for the detection of the Lassa virus].
    Vladyko AS; Kramarenko LP; Cherednichenko IA; Surikova LE
    Vopr Virusol; 1988; 33(4):498-502. PubMed ID: 3195147
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation and use of erythrocyte-globulin conjugates to Lassa virus in reversed passive hemagglutination and inhibition.
    Goldwasser RA; Elliott LH; Johnson KM
    J Clin Microbiol; 1980 Jun; 11(6):593-9. PubMed ID: 7000810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect solid-phase immunosorbent assay for detection of arenavirus antigens and antibodies.
    Ivanov AP; Rezapkin GV; Dzagurova TK; Tkachenko EA
    Acta Virol; 1984 May; 28(3):240-5. PubMed ID: 6148001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dynamics of antigen and antibody accumulation in adult mice, infected with Lassa virus].
    Vladyko AS; Surikova LE; Kramarenko LP; Bystrova SI; Torop AV
    Vopr Virusol; 1989; 34(1):100-3. PubMed ID: 2658319
    [No Abstract]   [Full Text] [Related]  

  • 5. Differentiation between two African arenaviruses (Lassa and Mozambique) by plaque assay.
    Tomori O; Johnson K
    Acta Virol; 1987 Mar; 31(2):146-51. PubMed ID: 2886023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to Lassa and Lassa-like viruses in man and mammals in the Central African Republic.
    Georges AJ; Gonzalez JP; Abdul-Wahid S; Saluzzo JF; Meunier DM; McCormick JB
    Trans R Soc Trop Med Hyg; 1985; 79(1):78-9. PubMed ID: 2986324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of the immune response in mice immunized with the inactivated Lassa virus].
    Ignat'ev GM; Golubev VP; Godneva AT; Petkevich AS; Torop AV
    Vopr Virusol; 1989; 34(2):213-6. PubMed ID: 2474905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of betapropionolactone inactivated Ebola, Marburg and Lassa intracellular antigens in immunofluorescent antibody assay.
    Van der Groen G; Elliot LH
    Ann Soc Belg Med Trop; 1982 Mar; 62(1):49-54. PubMed ID: 7049096
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys.
    Johnson KM; Elliott LH; Heymann DL
    J Clin Microbiol; 1981 Nov; 14(5):527-9. PubMed ID: 7031084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay.
    Niklasson BS; Jahrling PB; Peters CJ
    J Clin Microbiol; 1984 Aug; 20(2):239-44. PubMed ID: 6386846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of monoclonal antibodies against Lassa virus].
    Vladyko AS; Bystrova SI; Lemeshko NN; Lukashevich IS
    Mol Gen Mikrobiol Virusol; 1987 May; (5):37-40. PubMed ID: 2441254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The localization and preliminary characteristics of antigenic sites (B epitopes) in the nucleocapsid protein of the Lassa virus].
    Vladyko AS; Bystrova SI; Malakhova IV; Kunitskaia LIa; Lemeshko NN; Kras'ko AG; Kozhich AT; Lukashevich IS
    Vopr Virusol; 1993; 38(1):30-4. PubMed ID: 7521097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lassa fever virus in Senegal.
    Saluzzo JF; Adam F; McCormick JB; Digoutte JP
    J Infect Dis; 1988 Mar; 157(3):605. PubMed ID: 3343533
    [No Abstract]   [Full Text] [Related]  

  • 14. [Indirect immunoenzyme method for the laboratory diagnosis of Lassa and Ebola hemorrhagic fevers].
    Ivanov AP; Tkachenko EA; van der Groen G; Butenko AM; Konstantinov OK
    Vopr Virusol; 1986; 31(2):186-90. PubMed ID: 3524001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Ippy as a Lassa-fever-related virus.
    Swanepoel R; Leman PA; Shepherd AJ; Shepherd SP; Kiley MP; McCormick JB
    Lancet; 1985 Mar; 1(8429):639. PubMed ID: 2857974
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin.
    Jahrling PB
    J Med Virol; 1983; 12(2):93-102. PubMed ID: 6619814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological survey for the detection of antibodies to lassa virus in India.
    Rodrigues FM; Gupta NP; Pinto BD
    J Indian Med Assoc; 1978 Jan; 70(2):25-8. PubMed ID: 659905
    [No Abstract]   [Full Text] [Related]  

  • 18. Modifications to indirect immunofluorescence tests on Lassa, Marburg, and Ebola material.
    van der Groen G; Kurata T; Mets C
    Lancet; 1983 Mar; 1(8325):654. PubMed ID: 6131336
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunization of rabbits with Lassa virus].
    Orlova SV; Godneva AT; Ignat'ev GM; Bystrova SI
    Vopr Virusol; 1990; 35(1):59-61. PubMed ID: 2363276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serology and virulence diversity among Old-World arenaviruses, and the relevance to vaccine development.
    Jahrling PB; Peters CJ
    Med Microbiol Immunol; 1986; 175(2-3):165-7. PubMed ID: 3724664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.